RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, J Motion et al.|Cancer Epidemiology Biomarkers & Prevention|2017Cited by 6
Data from RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Linda Ashcroft et al.|Unknown|2023Cited by 0
Supplementary Table 1 from RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Linda Ashcroft et al.|Unknown|2023Cited by 0
Supplementary Table 1 from RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Linda Ashcroft et al.|Unknown|2023Cited by 0
Data from RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast CancerAnthony Howell, D. Gareth Evans, Linda Ashcroft et al.|Unknown|2023Cited by 0